Both cefixime and cefixime + SLBZS treatments decreased the CRP, PCT, IFN-γ, TNF-α, IL-1β, IL-6, and IL-8 levels and increased IL-10 levels in serum of children with pneumonia. The gene discussed is CRP; the disease is susceptibility to pneumonia measurement.